Sort
64,565 grants matching “drug discovery”
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
$475,000Laurence J Miller · Mayo Clinic Arizona · R01 · FY2017 · HL
Pharmacological targeting of circadian clock components to treat glioblastoma
$475,000Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2021 · CA
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
$474,999Hans Renata · Scripps Florida · R35 · FY2021 · GM
Synergistic killing of bacterial pathogens by histones
$474,960Albert Siryaporn · University Of California-Irvine · R01 · FY2025 · AI
Synergistic killing of bacterial pathogens by histones
$474,960Albert Siryaporn · University Of California-Irvine · R01 · FY2023 · AI
Synergistic killing of bacterial pathogens by histones
$474,960Albert Siryaporn · University Of California-Irvine · R01 · FY2024 · AI
Kinome Drug Bioassay Platform
$474,950Haiching Ma · Reaction Biology Corporation · R44 · FY2006 · CA
Function of MVFR in Pseudomonas Aeruginosa Virulence
$474,950Laurence G Rahme · Massachusetts General Hospital · R56 · FY2012 · AI
Multipurpose Device for Female-initiated Nonsteroidal On-Demand Contraception
$474,946Giovanni M Pauletti · St. Louis College Of Pharmacy · R61 · FY2025 · HD
Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular Probes
$474,944Vy M Dong · University Of California-Irvine · R35 · FY2023 · GM
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$474,941Kendall Jay Blumer · Washington University · R01 · FY2021 · GM
Autoantigens for Diabetogenic CD4 T Cells
$474,915Kathryn Haskins · University Of Colorado Denver · R01 · FY2014 · DK
Autoantigens for Diabetogenic CD4 T Cells
$474,915Kathryn Haskins · University Of Colorado Denver · R01 · FY2012 · DK
Autoantigens for Diabetogenic CD4 T Cells
$474,915Kathryn Haskins · University Of Colorado Denver · R01 · FY2015 · DK
Protein Chemistry
$474,861Ronald T Raines · Massachusetts Institute Of Technology · R35 · FY2024 · GM
Protein Chemistry
$474,861Ronald T Raines · Massachusetts Institute Of Technology · R35 · FY2023 · GM
Small Molecule Approaches to Targeting the DNA and RNA in Myotonic Dystrophy
$474,854Steven C. Zimmerman · University Of Illinois At Urbana-Champaign · R01 · FY2019 · AR
Small Molecule Approaches to Targeting the DNA and RNA in Myotonic Dystrophy
$474,854Steven C. Zimmerman · University Of Illinois At Urbana-Champaign · R01 · FY2020 · AR
Pre-clinical testing of a novel immunotherapy [recombinant T cell receptor ligand
$474,779Jennifer M Loftis · Oregon Health & Science University · RC1 · FY2009 · DA
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics
$474,777David Elihu Greenberg · Ut Southwestern Medical Center · R33 · FY2016 · AI
Drug Action, Metabolism and Kinetics
$474,763William M Atkins · University Of Washington · T32 · FY2015 · GM
Suppression of the Interferon Response by the Hepatitis C Virus
$474,750Francis Vincent Chisari · Scripps Research Institute, The · R56 · FY2010 · AI
Structure-function studies of IP3R channels
$474,723Irina I Serysheva · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · GM
AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
$474,721Nelson J. Chao · Duke University · UG3 · FY2018 · TR
PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes
$474,712David A Baker · Marquette University · R01 · FY2021 · DA